Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion. (Q33329060)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion. |
scientific article |
Statements
1 reference
Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion. (English)
1 reference
J P Stevenson
1 reference
D DeMaria
1 reference
J Sludden
1 reference
S B Kaye
1 reference
L Paz-Ares
1 reference
L B Grochow
1 reference
A McDonald
1 reference
K Selinger
1 reference
P Wissel
1 reference
P J O'Dwyer
1 reference
C Twelves
1 reference
1 March 1999
1 reference
1 reference
10
1 reference
339-344
1 reference
Identifiers
1 reference
1 reference